135 related articles for article (PubMed ID: 16463658)
1. Expression of CD28 and CTLA4 on T cells in bone morrow of immune-mediated aplastic anemia mice.
Liu Z; Sun H; Liu W; Luo X; He L; Xu H
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(5):508-9, 515. PubMed ID: 16463658
[TBL] [Abstract][Full Text] [Related]
2. [Role of CD28/CTLA-4 co-stimulators in immune pathophysiology of aplastic anemia].
He GS; Zhou L; Wu DP; Sun AN; Miao M; Wang XL; Chang WR; Zhu ZL; Jin ZM; Qiu HY; Tang XW; Fu ZZ; Han Y; Ma X; Chen SN; Wu XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):590-3. PubMed ID: 18246813
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
[TBL] [Abstract][Full Text] [Related]
4. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
[TBL] [Abstract][Full Text] [Related]
5. Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86.
Lane P
Ann N Y Acad Sci; 1997 Apr; 815():392-400. PubMed ID: 9186685
[TBL] [Abstract][Full Text] [Related]
6. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
[TBL] [Abstract][Full Text] [Related]
7. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.
Fallarino F; Fields PE; Gajewski TF
J Exp Med; 1998 Jul; 188(1):205-10. PubMed ID: 9653097
[TBL] [Abstract][Full Text] [Related]
8. Regulation of T cell activation by CD28 and CTLA4.
Noel PJ; Boise LH; Thompson CB
Adv Exp Med Biol; 1996; 406():209-17. PubMed ID: 8910687
[TBL] [Abstract][Full Text] [Related]
9. [Study on the effect of ligustrazine on adherent molecule expression of bone marrow cells in immune-mediated aplastic anemia mice].
Dong L; Liu W; Sun H
Zhonghua Xue Ye Xue Za Zhi; 1999 Apr; 20(4):178-9. PubMed ID: 11601222
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD28 by bone marrow stromal cells and its involvement in B lymphopoiesis.
Gray Parkin K; Stephan RP; Apilado RG; Lill-Elghanian DA; Lee KP; Saha B; Witte PL
J Immunol; 2002 Sep; 169(5):2292-302. PubMed ID: 12193694
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of CTLA-4, CD28, VDR, and CD45 mRNA in T cells of patients with Hashimoto's thyroiditis - a pilot study.
Tokić S; Štefanić M; Karner I; Glavaš-Obrovac L
Endokrynol Pol; 2017; 68(3):274-828. PubMed ID: 28660994
[TBL] [Abstract][Full Text] [Related]
12. [Studies of bone marrow T lymphocytes in patients with aplastic anemia].
Zeng F; Shen B; Shi Q
Zhonghua Xue Ye Xue Za Zhi; 1997 Oct; 18(10):541-3. PubMed ID: 15625832
[TBL] [Abstract][Full Text] [Related]
13. CD28/CTLA4 double deficient mice demonstrate crucial role for B7 co-stimulation in the induction of allergic lower airways disease.
Deurloo DT; van Berkel MA; van Esch BC; Hofhuis F; Nijkamp FP; Oosterwegel MA; van Oosterhout AJ
Clin Exp Allergy; 2003 Sep; 33(9):1297-304. PubMed ID: 12956753
[TBL] [Abstract][Full Text] [Related]
14. CD28-specific antibody prevents graft-versus-host disease in mice.
Yu XZ; Bidwell SJ; Martin PJ; Anasetti C
J Immunol; 2000 May; 164(9):4564-8. PubMed ID: 10779758
[TBL] [Abstract][Full Text] [Related]
15. Molecular alterations in the TCR signaling pathway in patients with aplastic anemia.
Li B; Guo L; Zhang Y; Xiao Y; Wu M; Zhou L; Chen S; Yang L; Lu X; Li Y
J Hematol Oncol; 2016 Mar; 9():32. PubMed ID: 27036622
[TBL] [Abstract][Full Text] [Related]
16. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.
Greenfield EA; Howard E; Paradis T; Nguyen K; Benazzo F; McLean P; Höllsberg P; Davis G; Hafler DA; Sharpe AH; Freeman GJ; Kuchroo VK
J Immunol; 1997 Mar; 158(5):2025-34. PubMed ID: 9036945
[TBL] [Abstract][Full Text] [Related]
17. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia].
Shen R; Xu CG; Li LZ; Zhang T; Qin XM; Li J; Zhao CL
Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):209-12. PubMed ID: 15182557
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
Guo Y; Wu Y; Zhao M; Kong XP; Liu Y
J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334
[TBL] [Abstract][Full Text] [Related]
19. Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia.
Otawa M; Kawanishi Y; Iwase O; Shoji N; Miyazawa K; Ohyashiki K
Leuk Res; 2000 Apr; 24(4):359-66. PubMed ID: 10713334
[TBL] [Abstract][Full Text] [Related]
20. Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models.
Shin JH; Park HB; Oh YM; Lim DP; Lee JE; Seo HH; Lee SJ; Eom HS; Kim IH; Lee SH; Choi K
Blood; 2012 Jun; 119(24):5678-87. PubMed ID: 22538857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
